We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+13.12%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$23.6B
AUM Growth
+$1.71B
Cap. Flow
-$406M
Cap. Flow %
-1.72%
Top 10 Hldgs %
52.37%
Holding
196
New
43
Increased
37
Reduced
38
Closed
21

Top Buys

Rank Stock Value
1
HES
Hess
HES
+$502M
2
UNH icon
UnitedHealth
UNH
+$254M
3
ABNB icon
Airbnb
ABNB
+$243M
4
AON icon
Aon
AON
+$196M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$152M

Top Sells

Rank Stock Value
1
CHTR icon
Charter Communications
CHTR
+$311M
2
TMO icon
Thermo Fisher Scientific
TMO
+$228M
3
BX icon
Blackstone
BX
+$222M
4
TRU icon
TransUnion
TRU
+$203M
5
SPLK
Splunk Inc
SPLK
+$202M

Sector Composition

Rank Sector Weight
1 Healthcare 26.88%
2 Technology 10.2%
3 Financials 8.76%
4 Energy 8.1%
5 Industrials 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BEKE icon
51
KE Holdings
BEKE
$18.8B
$65.1M 0.28%
4,740,833
-17,667
-0.4% -$247K
LBPH
52
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$63.5M 0.27%
2,940,500
+1,380,000
+88% +$30.1M
ICLR icon
53
Icon
ICLR
$12.7B
$60.4M 0.26%
+179,700
New +$53M
EDU icon
54
New Oriental
EDU
$8.98B
$53.4M 0.23%
615,000
+602,000
+4,631% +$51.1M
XBI icon
55
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$47.4M 0.2%
+500,000
New +$46.4M
CERE
56
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$44.9M 0.19%
1,063,000
+495,679
+87% +$20.8M
BHVN icon
57
Biohaven
BHVN
$2.21B
$43.7M 0.19%
799,000
+49,000
+7% +$2.43M
ENTA icon
58
Enanta Pharmaceuticals
ENTA
$400M
$36.6M 0.16%
2,095,000
+70,000
+3% +$926K
EVH icon
59
Evolent Health
EVH
$447M
$34M 0.14%
1,037,331
-1,126,578
-52% -$36M
IONS icon
60
Ionis Pharmaceuticals
IONS
$9.4B
$31.8M 0.14%
734,000
-821,020
-53% -$39.1M
LQDA icon
61
Liquidia Corp
LQDA
$8.02B
$30.3M 0.13%
+2,055,000
New +$28.6M
HIMS icon
62
Hims & Hers Health
HIMS
$7.31B
$25.9M 0.11%
1,676,000
+1,634,000
+3,890% +$18.4M
PCVX icon
63
Vaxcyte
PCVX
$8.64B
$25.8M 0.11%
377,400
+374,000
+11,000% +$25.9M
UTHR icon
64
United Therapeutics
UTHR
$23.1B
$25.3M 0.11%
110,000
-366,000
-77% -$82.6M
GERN icon
65
Geron
GERN
$949M
$24.7M 0.1%
+7,495,000
New +$16.8M
BABA icon
66
Alibaba
BABA
$308B
$23.8M 0.1%
329,000
-206,000
-39% -$15.1M
PGNY icon
67
Progyny
PGNY
$2.2B
$22.6M 0.1%
+592,600
New +$22.4M
VYGR icon
68
Voyager Therapeutics
VYGR
$201M
$21.3M 0.09%
2,292,000
+1,000,000
+77% +$8.44M
PCG icon
69
PG&E
PCG
$38.5B
$21.3M 0.09%
1,271,642
-1,000,000
-44% -$16.8M
DFS
70
DELISTED
Discover Financial Services
DFS
$21M 0.09%
+160,000
New +$18.3M
APGE icon
71
Apogee Therapeutics
APGE
$10.2B
$20.3M 0.09%
+305,000
New +$13.3M
ELEV
72
DELISTED
Elevation Oncology
ELEV
$19.9M 0.08%
+3,886,663
New +$12.6M
HUM icon
73
Humana
HUM
$46.2B
$17.9M 0.08%
51,700
-69,644
-57% -$26.4M
SYRE icon
74
Spyre Therapeutics
SYRE
$9.25B
$17.7M 0.08%
+466,000
New +$13.5M
ARQT icon
75
Arcutis Biotherapeutics
ARQT
$3.18B
$17.6M 0.07%
+1,780,000
New +$13.3M
1 2
3
4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Farallon Capital Management held 196 positions worth $23.6B, up 7.8% from $21.9B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Farallon Capital Management's Q1 2024 filing shows 43 new, 37 increased, 38 reduced and 21 closed positions. Its largest new stake was Airbnb: 1,608,220 shares worth $265M. The largest sale was Charter Communications, an estimated $311M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

  • Farallon Capital Management's largest Q1 2024 buy was Airbnb: 1,608,220 shares worth $265M.
  • Farallon Capital Management added most to Hess in Q1 2024, an estimated $502M increase.
  • Farallon Capital Management's biggest Q1 2024 reduction was Thermo Fisher Scientific, cutting an estimated $228M.
  • Farallon Capital Management fully exited Charter Communications in Q1 2024, selling an estimated $311M.
  • Farallon Capital Management's ten largest holdings make up 52% of its $23.6B portfolio in Q1 2024.
  • Farallon Capital Management opened 43 new positions and closed 21 in Q1 2024.
  • Farallon Capital Management's portfolio value rose 7.8% quarter-over-quarter to $23.6B.

Based on Farallon Capital Management's 13F filing for Q1 2024, filed 15 May 2024.